Two-Dose H1N1 Vaccination Might Be Optimal, But Would Stress Supply
An FDA panel said the H1N1 flu vaccine should be given in two doses when the probable vaccine campaign starts in the fall, but government officials at the meeting said there will not likely be enough vaccine available at that point to follow that advice
You may also be interested in...
Multi-faceted effort includes text messages to vaccinees, a grant for Johns Hopkins, and extra funding for 10 state health departments.
Adequate supply of the vaccine is key to FDA's determination of whether to approve adjuvanted H1N1 vaccines.
The National Institutes of Health is developing a plan B as H1N1 vaccine manufacturers race to produce enough product by the start of flu season. The agency is going to mix and match antigen and adjuvant from different sponsors to try to find the best immunogenicity